AOD-9604 vs PE 22-28
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of AOD-9604 and PE 22-28 (also searched as PE 22-28 vs AOD-9604) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
AOD-9604 centers on metabolic, while PE 22-28 leans toward metabolic. On indexed research, PE 22-28 is ahead (AOD-9604: 4 studies, Human evidence; PE 22-28: 5, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •AOD-9604 is strongest for metabolic; PE 22-28 for metabolic.
- •Evidence: AOD-9604 Human evidence (4 studies) vs PE 22-28 Human evidence (5).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
AOD-9604 vs PE 22-28: side-by-side
| Metric | AOD-9604 | PE 22-28 |
|---|---|---|
| Class | Weight Loss | Cognitive |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 4 | 5 |
| Research level | Well Studied | Emerging |
| Strongest effect | Metabolic & appetite | Metabolic & appetite |
| Healing & recovery | 3.0▲ | 2.0 |
| Muscle & body comp | 0.0 | 0.0 |
| Metabolic & appetite | 4.0▲ | 4.0▲ |
| Neuro & mood | 0.0 | 3.0▲ |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 0.0 | 2.0▲ |
| Skin & aesthetics | 2.0▲ | 0.0 |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | AOD-9604 | PE 22-28 |
|---|---|---|
| Mechanism | Modified hGH fragment (176–191) | — |
| Route | Subcutaneous injection (research use) | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is AOD-9604?
A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.
Full AOD-9604 profile, mechanism & studies →What is PE 22-28?
### Summary PE 22-28 is a peptide that has garnered attention in various research contexts, particularly in relation to vascular health and metabolic conditions. Its potential implications in gestational diabetes and placental function are areas of ongoing investigation.
Full PE 22-28 profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | AOD-9604 | 3.0/5 effect signal |
| Metabolic | Even | Both ~4.0/5 |
| Neuro | PE 22-28 | 3.0/5 effect signal |
| Inflammation | PE 22-28 | 2.0/5 effect signal |
| Skin | AOD-9604 | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack AOD-9604 and PE 22-28?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
AOD-9604 vs PE 22-28: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
AOD-9604 has 4 approved studies indexed (Human evidence), and PE 22-28 has 5 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is AOD-9604 or PE 22-28 better?
It depends on your goal. AOD-9604 is strongest for metabolic; PE 22-28 for metabolic. PE 22-28 has more indexed studies (5). See the goal-by-goal breakdown above.
Is AOD-9604 or PE 22-28 better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Which has more research, AOD-9604 or PE 22-28?
AOD-9604 has 4 approved studies indexed (Human evidence); PE 22-28 has 5 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack AOD-9604 and PE 22-28?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of AOD-9604 vs PE 22-28?
AOD-9604: no community-reported effects logged yet. PE 22-28: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is AOD-9604 or PE 22-28 FDA-approved?
AOD-9604 is a research-use compound and is not FDA-approved. PE 22-28 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is PE 22-28 better than AOD-9604?
For metabolic, PE 22-28 has the edge; for metabolic, AOD-9604 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
AOD-9604 and PE 22-28 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.